Corrigendum to: Luteolin inhibits pyrogallol-induced apoptosis through the extracellular signal-regulated kinase signaling pathway: Luteolin inhibits pyrogallol-induced apoptosis (FEBS Journal, (2012), 279, 10, (1834-1843), 10.1111/j.1742-4658.2012.08558.x);Luteolin inhibits pyrogallol-induced apoptosis through the extracellular signal-regulated kinase signaling pathway

FEBS Journal

Volumn 279, Issue 10, 2012, Pages 1834-1843

  He, Dongxu ^a   Ma, Xin ^a   Chen, Yun ^a   Cai, Yanfei ^a   Ru, Xiaochen ^b   Bruce, Iain C ^b   Xia, Qiang ^b   Shi, Guiyang ^a   Jin, Jian ^a  

^a JIANGNAN UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

apoptosis; endothelial dysfunction; luteolin; mitogen activated protein kinases; pyrogallol

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; DNA; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; LUTEOLIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PYROGALLOL; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CAPILLARY ENDOTHELIUM; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOCHEMISTRY; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME DEGRADATION; FLOW CYTOMETRY; INHIBITION KINETICS; MITOCHONDRIAL MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

EID: 84860348228     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.16620     Document Type: Erratum

References (30)

1. Schiffrin EL, (1994) The endothelium and control of blood vessel function in health and disease. Clin Invest Med 17, 602-620.
2. Palmer RM, Ferrige AG, &, Moncada S, (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327, 524-526. (Pubitemid 17085822)
3. Gryglewski RJ, Moncada S, &, Palmer RM, (1997) Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells. 1985. Br J Pharmacol 120, 494-503. (Pubitemid 127732630)
4. Ma X, Li YF, Gao Q, Ye ZG, Lu XJ, Wang HP, Jiang HD, Bruce IC, &, Xia Q, (2008) Inhibition of superoxide anion-mediated impairment of endothelium by treatment with luteolin and apigenin in rat mesenteric artery. Life Sci 83, 110-117.
5. Katusic ZS, (1996) Superoxide anion and endothelial regulation of arterial tone. Free Radic Biol Med 20, 443-448. (Pubitemid 26077867)
6. Stefanec T, (2000) Endothelial apoptosis: could it have a role in the pathogenesis and treatment of disease? Chest 117, 841-854. (Pubitemid 30152229)
7. Stefanec T, (1999) Endothelial apoptosis in scleroderma: comment on the article by Black et al. Arthritis Rheum 42, 2491.
8. Irani K, (2000) Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 87, 179-183. (Pubitemid 30626423)
9. Hogg N, Browning J, Howard T, Winterford C, Fitzpatrick D, &, Gobe G, (1999) Apoptosis in vascular endothelial cells caused by serum deprivation, oxidative stress and transforming growth factor-beta. Endothelium 7, 35-49. (Pubitemid 29481522)
10. Gobe G, Browning J, Howard T, Hogg N, Winterford C, &, Cross R, (1997) Apoptosis occurs in endothelial cells during hypertension-induced microvascular rarefaction. J Struct Biol 118, 63-72. (Pubitemid 27521195)
11. Bombeli T, Karsan A, Tait JF, &, Harlan JM, (1997) Apoptotic vascular endothelial cells become procoagulant. Blood 89, 2429-2442. (Pubitemid 27143290)
12. Qian LB, Wang HP, Chen Y, Chen FX, Ma YY, Bruce IC, &, Xia Q, (2010) Luteolin reduces high glucose-mediated impairment of endothelium-dependent relaxation in rat aorta by reducing oxidative stress. Pharmacol Res 61, 281-287.
13. Horinaka M, Yoshida T, Shiraishi T, Nakata S, Wakada M, Nakanishi R, Nishino H, Matsui H, &, Sakai T, (2005) Luteolin induces apoptosis via death receptor 5 upregulation in human malignant tumor cells. Oncogene 24, 7180-7189. (Pubitemid 41679280)
14. Ueda H, Yamazaki C, &, Yamazaki M, (2003) Inhibitory effect of Perilla leaf extract and luteolin on mouse skin tumor promotion. Biol Pharm Bull 26, 560-563. (Pubitemid 39663608)
15. Ueda H, Yamazaki C, &, Yamazaki M, (2002) Luteolin as an anti-inflammatory and anti-allergic constituent of Perilla frutescens. Biol Pharm Bull 25, 1197-1202. (Pubitemid 39655163)
16. Ueda H, Yamazaki C, &, Yamazaki M, (2004) A hydroxyl group of flavonoids affects oral anti-inflammatory activity and inhibition of systemic tumor necrosis factor-alpha production. Biosci Biotechnol Biochem 68, 119-125. (Pubitemid 39251573)
17. Zhou Y, Wang Q, Evers BM, &, Chung DH, (2005) Signal transduction pathways involved in oxidative stress-induced intestinal epithelial cell apoptosis. Pediatr Res 58, 1192-1197.
18. Xia Z, Dickens M, Raingeaud J, Davis RJ, &, Greenberg ME, (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326-1331.
19. Roux PP, &, Blenis J, (2004) ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 68, 320-344. (Pubitemid 38756868)
20. Benhar M, Dalyot I, Engelberg D, &, Levitzki A, (2001) Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol Cell Biol 21, 6913-6926. (Pubitemid 32911252)
21. Hsieh CC, &, Papaconstantinou J, (2006) Thioredoxin-ASK1 complex levels regulate ROS-mediated p38 MAPK pathway activity in livers of aged and long-lived Snell dwarf mice. FASEB J 20, 259-268. (Pubitemid 44933173)
22. Hsieh CC, Kuro-o M, Rosenblatt KP, Brobey R, &, Papaconstantinou J, (2010) The ASK1-signalosome regulates p38 MAPK activity in response to levels of endogenous oxidative stress in the Klotho mouse models of aging. Aging (Albany, NY) 2, 597-611.
23. Guerrero I, Wong H, Pellicer A, &, Burstein DE, (1986) Activated N-ras gene induces neuronal differentiation of PC12 rat pheochromocytoma cells. J Cell Physiol 129, 71-76. (Pubitemid 17178528)
24. Zachary I, (1998) Vascular endothelial growth factor: how it transmits its signal. Exp Nephrol 6, 480-487. (Pubitemid 28518369)
25. Johnson GL, &, Lapadat R, (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911-1912. (Pubitemid 35425238)
26. Bagli E, Stefaniotou M, Morbidelli L, Ziche M, Psillas K, Murphy C, &, Fotsis T, (2004) Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity. Cancer Res 64, 7936-7946. (Pubitemid 39446927)
27. Parenti A, Morbidelli L, Cui XL, Douglas JG, Hood JD, Granger HJ, Ledda F, &, Ziche M, (1998) Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium. J Biol Chem 273, 4220-4226. (Pubitemid 28103293)
28. Zhou F, Qu L, Lv K, Chen H, Liu J, Liu X, Li Y, &, Sun X, (2011) Luteolin protects against reactive oxygen species-mediated cell death induced by zinc toxicity via the PI3K-Akt-NF-kappaB-ERK-dependent pathway. J Neurosci Res 89, 1859-1868.
29. Kim MJ, Woo JS, Kwon CH, Kim JH, Kim YK, &, Kim KH, (2011) The flavonoid luteolin induces apoptotic cell death through AIF nuclear translocation mediated by activation of ERK and p38 in human breast cancer cell lines. Cell Biol Int 36, 339-344.
30. McCord JM, &, Fridovich I, (1969) Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244, 6049-6055.